Karl Heinz Kuck

Asklepios Klinik St. Georg

Papers

1

Total Citations

19

H-Index

1

About

Karl Heinz Kuck is a pioneering figure in cardiac electrophysiology, whose work has fundamentally shaped the treatment of atrial fibrillation (AF). His primary research focuses on catheter ablation techniques, particularly pulmonary vein isolation (PVI), which has become the cornerstone of AF therapy. Kuck’s major contributions include advancing the understanding and procedural execution of circumferential PVI using irrigated radiofrequency, a technique that dramatically improved patient outcomes. He is also known for his leadership in comparative effectiveness research, such as the landmark "Man and Machine" trial, which prospectively evaluated manual versus robotic catheter ablation for AF. With over 19 citations on that study alone and a career spanning hundreds of influential papers, Kuck’s impact is immense. He has been instrumental in designing rigorous, international trials that set new standards for safety and efficacy in interventional electrophysiology. His work has not only refined ablation strategies but also paved the way for robotic-assisted precision, making him a central figure in modern arrhythmia management.

Research Focus

Key Achievements

1
H-Index
1
Papers
19
Total Citations
19
Avg Citations/Paper
🏆 Most Cited Paper
Study Design of the Man and Machine Trial: A Prospective International Controlled Noninferiority Trial Comparing Manual with Robotic Catheter Ablation for Treatment of Atrial Fibrillation
19 citations · 2012
📈 Most Prolific Year: 2012 (1 Papers)
🤝 Key Collaborators: 16
🏛 Institutions: Asklepios Klinik St. Georg

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago